Publications by authors named "Hugo Luzardo"

Claim this Profile
T
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Gloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, Víctor Navarro, Tobias Menne, Hugo Luzardo

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
Mariana Bastos-Oreiro, Pau Abrisqueta, Antonio Gutierrez, Ana Jiménez Ubieto, Maria Poza, Hugo Luzardo

Hemasphere· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.
María Nieves Saez Perdomo, Ruth Stuckey, Elena González-Pérez, Santiago Sánchez-Sosa, Paula Estupiñan-Cabrera, Hugo Luzardo

Hematol Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Josep-Maria Ribera, Mireia Morgades, Olga Garcia-Calduch, Maialen Sirvent, Buenaventura Buendia, Hugo Luzardo

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Mariana Bastos-Oreiro, Antonio Gutierrez, Gloria Iacoboni, Lucía López Corral, Juan Luis Reguera, Hugo Luzardo

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
Mariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, Gloria Iacoboni, Lucía López-Corral, Hugo Luzardo

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Antonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, Gilberto Barranco, Marta Garcia-Recio, Hugo Luzardo

Eur J Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Mariana Bastos-Oreiro, Ana Muntañola, Carlos Panizo, Eva Gonzalez-Barca, Sonia González de Villambrosia, Hugo Luzardo

Ann Hematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
Leyre Bento, Antonio Díaz-López, Gilberto Barranco, Ana M Martín-Moreno, Mónica Baile, Hugo Luzardo

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis.
Silvia De-la-Iglesia, Hugo Luzardo, Angelina Lemes, Melissa Torres, Maria Teresa Gómez-Casares

Hematol Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission after a year of romiplostim in an adult patient with refractory primary immune thrombocytopenia.
Maria Perera, Alexia Suarez, Hugo Luzardo, Jezabel Lopez, Teresa Molero

Ann Hematol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis